Levocetirizine and rupatadine in chronic idiopathic urticaria

Levocetrizine has anti-inflammatory effects against Toll-like receptor (TLR)3 through the inhibition of Toll-IL-1 receptor (TIR)-domain-containing adapter inducing IFN-beta (TRIF) and receptor-interacting protein (RIP)

(2011) Chan-Soon Park et al.   AURIS NASUS LARYNX

Add-on montelukast in antihistamine-resistant chronic idiopathic urticaria

(2011) Mitja Kosnik et al.   RESPIRATORY MEDICINE

Loratadine versus levocetirizine in chronic idiopathic urticaria:A comparative study of efficacy and safety

(2010) Rituparna Maiti et al.   INDIAN JOURNAL OF PHARMACOLOGY

The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria

(2010) Maria Staevska et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children

(2009) Devada Singh-Franco et al.   CLINICAL THERAPEUTICS

The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo- controlled treatment with rupatadine 10 and 20 mg

(2009) A Giménez-Arnau et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients

(2008) P. C. Potter et al.   ALLERGY